Measles, Mumps, Rubella and Chickenpox (live vaccine)

BIOLOGICAL3 trials

Sponsors

GlaxoSmithKline

Conditions

MeaslesMumpsRubellaVaricella

Phase 3

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

CompletedNCT00127023

GlaxoSmithKlineMeasles, Mumps, Rubella +1

Start: 2005-05-31End: 2005-11-30Target: 944Updated: 2016-09-21

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

CompletedNCT00127010

GlaxoSmithKlineMeasles, Mumps, Rubella +1

Start: 2005-11-30End: 2006-06-30Updated: 2016-09-26

Phase 4

Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

CompletedNCT00126997

GlaxoSmithKlineMeasles, Mumps, Rubella +1

Start: 2005-05-31End: 2005-11-30Updated: 2016-09-21

Related Papers

Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.

2008-08-0134 citations